What is the recommended adult dosing regimen for liquid guaifenesin (200 mg) combined with codeine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adult Dosing for Guaifenesin with Codeine Liquid

For guaifenesin 200mg combined with codeine liquid in adults, the standard dosing is 10 mL (containing guaifenesin 200mg) every 4 hours, not exceeding 6 doses in 24 hours, with codeine typically dosed at 30-60 mg four times daily when used as an antitussive. 1, 2

Standard Dosing Regimen

Guaifenesin Component

  • Adults and children ≥12 years: 10-20 mL (2-4 teaspoonfuls) every 4 hours 2
  • Maximum: Do not exceed 6 doses in 24 hours 1, 2
  • The 200mg dose falls within the standard range of 200-400mg per dose 3

Codeine Component

  • Standard antitussive dose: 30-60 mg four times daily (qid) 4
  • This translates to dosing every 4-6 hours as needed for cough suppression 4

Clinical Context and Important Caveats

Codeine Is Not First-Line

Codeine is less preferred among opioid antitussives due to its greater side effect profile compared to alternatives like pholcodine, hydrocodone, or dihydrocodeine. 4 The 2017 CHEST guidelines specifically note that codeine, despite being the most researched drug for cough, has more adverse effects than other opioid derivatives based on expert consensus 4.

Genetic Considerations - Critical Safety Issue

  • Avoid codeine entirely in CYP2D6 ultrarapid metabolizers due to risk of increased toxicity from excessive conversion to morphine 5
  • Avoid codeine in CYP2D6 poor metabolizers due to lack of analgesic/antitussive effect, as they cannot convert codeine to its active metabolite 5
  • Consider pharmacogenomic testing if concerns about toxicity or lack of response arise 5

Appropriate Clinical Use

The combination should be reserved for:

  • Chronic bronchitis with cough where central cough suppressants are indicated 6
  • Cough unresponsive to demulcents (simple syrups, glycerol-based preparations) 4
  • Situations where the patient requires both expectorant action (guaifenesin) and cough suppression (codeine)

Monitoring and Duration

  • If no improvement after a short course, discontinue and try alternative approaches rather than continuing ineffective treatment 4
  • Monitor for typical opioid side effects: constipation, sedation, respiratory depression 4
  • The guaifenesin component requires multiple daily doses to maintain 24-hour therapeutic effect with immediate-release formulations 3

Safer Alternatives to Consider

For cough suppression, consider these alternatives before or instead of codeine:

  • Dextromethorphan: 10-30 mg every 4-6 hours (maximum 120 mg/day) 4, 7
  • Pholcodine: 10 mL four times daily (where available) 4
  • Dihydrocodeine: 10 mg three times daily 4

The guaifenesin component can be continued with these alternative antitussives if expectorant action is desired 8, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.